Dr Fuad B Mudawwar, MD | |
269 Locust St, Suite 201, Florence, MA 01062-2003 | |
(413) 586-0769 | |
(413) 584-0392 |
Full Name | Dr Fuad B Mudawwar |
---|---|
Gender | Male |
Speciality | Allergy & Immunology - Allergy |
Location | 269 Locust St, Florence, Massachusetts |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1225029713 | NPI | - | NPPES |
24219108 | Medicaid | MA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207KA0200X | Allergy & Immunology - Allergy | 41712 (Massachusetts) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Fuad B Mudawwar, MD 269 Locust St, Suite 201, Northampton, MA 01062-2003 Ph: (413) 586-0769 | Dr Fuad B Mudawwar, MD 269 Locust St, Suite 201, Florence, MA 01062-2003 Ph: (413) 586-0769 |
News Archive
Pharmacyclics, Inc. has announced that the U.S. Food and Drug Administration (FDA) has filed the company's New Drug Application (NDA) for Xcytrin (motexafin gadolinium) Injection.
Researchers at IIT-Istituto Italiano di Tecnologia fabricated an artificial device reproducing a 1:1 scale model of the blood-brain barrier, the anatomical and functional structure that protects the central nervous system from external substances, such as contaminants, but also drugs when they are injected intravenously into the body.
A new study published as "Editor's Choice" in The Journal of Infectious Diseases found that expansion of HIV treatment eligibility to include those under age 15 led to large and significant increases in initiation of antiretroviral therapy within 30 days of enrollment in care among 10- to 14-year-olds living with HIV.
Roche announced today the opening of a new state-of-the-art clinical supply manufacturing facility on its campus in Nutley, N.J. The Roche Center of Excellence produces dosage forms of highly potent compounds for preclinical safety studies, and Phase 1 and 2 clinical studies.
› Verified 4 days ago